Company Information

CSL (ASX:CSL) is a leading global biotherapeutics company with a dynamic portfolio of life-saving innovations, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL — including our two businesses CSL Behring and Seqirus — conducts business in over 60 countries with more than 17,000 employees. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest.
With major facilities in Australia, Germany, Switzerland, United Kingdom and the U.S., CSL employs over 17,000 employees working in more than 30 countries.


 

CSL Limited Business Structure
        
Global Leadership Group Global
Leadership Group >
CSL Limited
Annual Report >
CSL Limited Corporate Responsibility Report CSL Limited
Corporate Responsibility Report >
CSL Limited Product Pipeline CSL Limited
Product Pipeline >



CSL at a Glance

© 2017 CSL Limited